From: Single-center experience of induction therapy in non-systemic vasculitic neuropathy
CS MONO | CYC MONO | CS PULSE MONO | Combination therapy | P-value | |
---|---|---|---|---|---|
Count (n) | 13 | 10 | 9 | 5 | |
Sex (n) (male/female) | 11/ 2 | 7/3 | 5/4 | 3/2 | |
Age (years) | 64 (52.5, 73) | 70 (58.75, 77.25) | 68 (60, 75.5) | 59 (44.5, 74) | 0.318 |
Pallesthesia (0–8) | 2 (0, 3.5) | 2 (0, 3.25) | 2 (0, 3.5) | 2 (0, 3.5) | 0.998 |
CMAP tibial [mV] | 0.4 (0.05, 1.05) | 0.4 (0.075, 1) | 1.3 (0.45, 3.8) | 1.8 (0.3, 14.9) | 0.148 |
SNAP sural [µV] | 0.1 (0, 3.5) | 0 (0, 2.25) | 2 (0, 4.5) | 0 (0, 0) | 0.208 |
Disease duration before therapy (years) | 1.5 (1, 4) | 2 (1, 3.5) | 2 (2, 3) | 1 (0.79, 3) | 0.299 |